TY - JOUR
T1 - Present and future of parkinson's disease in Spain :
T2 - Parkinson-2030 delphi project
AU - Santos García, Diego
AU - Blázquez Estrada, Marta
AU - Calopa, Matilde
AU - Escamilla Sevilla, Francisco
AU - Freire, Eric
AU - García Ruiz, Pedro J.
AU - Grandas, Francisco
AU - Kulisevsky, Jaime
AU - López Manzanares, Lydia
AU - Martínez-Castrillo, Juan Carlos
AU - Mir, Pablo
AU - Pagonabarraga Mora, Javier
AU - Pérez-Errazquin, Francisco
AU - Salom, José María
AU - Tijero, Beatriz
AU - Valldeoriola, Francesc
AU - Yáñez, Rosa
AU - Avilés, Arantxa
AU - Luquin, Maria-Rosario
PY - 2021
Y1 - 2021
N2 - Parkinson's disease (PD) is a chronic progressive and irreversible disease and the second most common neurodegenerative disease worldwide. In Spain, it affects around 120.000-150.000 individuals, and its prevalence is estimated to increase in the future. PD has a great impact on pa-tients' and caregivers' lives and also entails a substantial socioeconomic burden. The aim of the present study was to examine the current situation and the 10-year PD forecast for Spain in order to optimize and design future management strategies. This study was performed using the modified Delphi method to try to obtain a consensus among a panel of movement disorders experts. Accord-ing to the panel, future PD management will improve diagnostic capacity and follow-up, it will include multidisciplinary teams, and innovative treatments will be developed. The expansion of new technologies and studies on biomarkers will have an impact on future PD management, leading to more accurate diagnoses, prognoses, and individualized therapies. However, the socio-economic impact of the disease will continue to be significant by 2030, especially for patients in advanced stages. This study highlighted the unmet needs in diagnosis and treatment and how crucial it is to establish recommendations for future diagnostic and therapeutic management of PD.
AB - Parkinson's disease (PD) is a chronic progressive and irreversible disease and the second most common neurodegenerative disease worldwide. In Spain, it affects around 120.000-150.000 individuals, and its prevalence is estimated to increase in the future. PD has a great impact on pa-tients' and caregivers' lives and also entails a substantial socioeconomic burden. The aim of the present study was to examine the current situation and the 10-year PD forecast for Spain in order to optimize and design future management strategies. This study was performed using the modified Delphi method to try to obtain a consensus among a panel of movement disorders experts. Accord-ing to the panel, future PD management will improve diagnostic capacity and follow-up, it will include multidisciplinary teams, and innovative treatments will be developed. The expansion of new technologies and studies on biomarkers will have an impact on future PD management, leading to more accurate diagnoses, prognoses, and individualized therapies. However, the socio-economic impact of the disease will continue to be significant by 2030, especially for patients in advanced stages. This study highlighted the unmet needs in diagnosis and treatment and how crucial it is to establish recommendations for future diagnostic and therapeutic management of PD.
KW - Diagnosis
KW - Economic impact
KW - Epidemiology
KW - Management
KW - Mortality
KW - Parkinson's disease
KW - Quality of life
KW - Spain
KW - Treatment
U2 - 10.3390/brainsci11081027
DO - 10.3390/brainsci11081027
M3 - Article
C2 - 34439646
SN - 2076-3425
VL - 11
JO - Brain Sciences
JF - Brain Sciences
IS - 8
ER -